Alison L. Allan

London, ON N6A5C1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Spatial proteomic profiling reveals an association between NF1-Ras/Raf/MEK signaling and immune cell infiltration in locally advanced triple-negative breast cancer.

Spatial proteomic profiling reveals an association between NF1-Ras/Raf/MEK signaling and immune cell infiltration in locally advanced triple-negative breast cancer.

Journal: Translational oncology

Published: April 13, 2026

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

Journal: BMC genomic data

Published: January 15, 2026

Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer.

Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer.

Journal: Cancers

Published: August 19, 2025

Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer.

Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer.

Journal: Carcinogenesis

Published: June 21, 2025

Clinical Utility of IFIT Proteins in Human Malignancies.

Clinical Utility of IFIT Proteins in Human Malignancies.

Journal: Biomedicines

Published: April 18, 2025

Investigation of effects of CFI-400945 and ionizing radiation on DNA damage response in triple-negative breast cancer.

Investigation of effects of CFI-400945 and ionizing radiation on DNA damage response in triple-negative breast cancer.

Journal: Translational cancer research

Published: December 10, 2024

Artemis and its role in cancer.

Artemis and its role in cancer.

Journal: Translational oncology

Published: June 13, 2024

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol.

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol.

Journal: BMC palliative care

Published: June 07, 2024

Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells.

Quality control and validation of extracellular vesicles isolated from cultured human breast cancer cells.

Journal: BMC research notes

Published: April 03, 2024

Centrosomes and associated proteins in pathogenesis and treatment of breast cancer.

Centrosomes and associated proteins in pathogenesis and treatment of breast cancer.

Journal: Frontiers in oncology

Published: January 14, 2024

Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis.

Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis.

Journal: Clinical & experimental metastasis

Published: October 14, 2023

Importance of Incorporating the Perspectives of People with Cancer into Oncology Education: A Scoping Review.

Importance of Incorporating the Perspectives of People with Cancer into Oncology Education: A Scoping Review.

Journal: Journal of medical education and curricular development

Published: August 23, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026